A panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to undertakings involving regular monitoring for fitness to practice nursing, remedial activities and a reprimand. The Agreement was sought following a report to BCCNP in 2019 that the Registrant had been diverting narcotics from the workplace from October 2018 to August 2019. An audit conducted by the employer revealed a pattern of narcotic diversion and altering of records to conceal the diversion. The Registrant admitted to the diversion and to a medical condition. Medical recommendations outlined treatment recommendations and conditions enabling a safe return to work.
Undertakings include but are not limited to: regular monitoring reports regarding compliance with treatment recommendations, disclosure of treatment recommendations to relevant employer representative(s), and a limit on the handling of narcotics, benzodiazepines, controlled substances and the "zed" class of drugs that is increasingly reduced in scope as the Registrant's period of successful abstinence lengthens, a limit on the areas that she may practice and a limit to not be in charge or have supervision over students or new hires. The Agreement will remain in place for a minimum of three years of continuous full-time nursing practice.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.